Research Article

Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification

Figure 4

The effects of GDFMD on autophagy and PI3K/Akt/mTOR pathway-related proteins in the liver of mouse models of WD. Expression of LC3 and Beclin-1 was observed using immunofluorescence staining (a); the protein levels of p-PI3K, PI3K, p-AKT, AKT, p-mTOR, mTOR, Beclin-1, p62, and LC3-II/LC3-I ratio (b) in liver tissues of mice from the normal, model, Gandoufumu (high dose, low dose, and middle dose), and penicillamine groups. Data is depicted in terms of (). compared with the normal group; compared with the model group.
(a)
(b)